Decentralized trials and biotech product needs are changing how investigational products reach patients. New market research reveals trends.
- Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development
- On The Potency Assurance Journey, Travelers Need A Road Map
- Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs
- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development
ON-DEMAND WEBINARS
This webinar brings together a panel of supply chain experts to bring insight into managing the uncertainty and risk that comes along with clinical supply decisions.
This webinar demystifies the term “agile,” from an operational perspective, while highlighting the speed and flexibility these systems offer to be able to support complex protocols that require accelerated changes.
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Learn how RTSM can be tailored to meet precision medicine’s unique challenges of expiry, visit & personalized shipment management.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![West Pharma]( "Key Considerations For Packaging Solutions For Cell And Gene Therapies")
Key Considerations For Packaging Solutions For Cell And Gene TherapiesThinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
![Singota]( "Faster From Formulation To Fill/Finish")
Faster From Formulation To Fill/FinishOptimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
![GettyImages-1312767504 data health]( "Using IRT Data To Automate And Optimize Clinical Supply")
Using IRT Data To Automate And Optimize Clinical SupplyLearn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
![check computer for vitals-GettyImages-1446748436]( "Finding The Optimal IRT/RTSM Design For Your Clinical Trial")
Finding The Optimal IRT/RTSM Design For Your Clinical TrialDetermine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
![GettyImages-893884852 doctors tablet data]( "Study, Not Software: Aligning RTSM To The Protocol")
Study, Not Software: Aligning RTSM To The ProtocolHow can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
-
![Refrigerated Container cold chain]( "Transportation Solutions For Cell And Gene Therapy Supply Chains")
Transportation Solutions For Cell And Gene Therapy Supply ChainsDeveloping a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
![GettyImages-1309776464-medical-research-analysis-lab-computer]( "IRT: A New Approach To Meeting The Needs Of Early Phase Trials")
IRT: A New Approach To Meeting The Needs Of Early Phase TrialsAs early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
![Quality Management GettyImages-1336716297]( "Quality Assured: Bringing Life-Changing Therapies To Patients")
Quality Assured: Bringing Life-Changing Therapies To PatientsBiopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
![GettyImages-1078167682-brexit-uk-ireland-eu]( "Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply Chain")
Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply ChainWith many BREXIT provisions now in effect and more to come, supply chains serving clinical trials in the UK and/or EU member states must navigate a complex web of new regulations.
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
